Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2008

01-10-2008 | Article

Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease

Authors: J. W. Baddley, J. R. Perfect, R. A. Oster, R. A. Larsen, G. A. Pankey, H. Henderson, D. W. Haas, C. A. Kauffman, R. Patel, A. K. Zaas, P. G. Pappas

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2008

Login to get access

Abstract

Cryptococcus neoformans is an uncommonly recognized cause of pneumonia in HIV-negative patients. Because of its propensity to disseminate to the meninges and other sites, a lumbar puncture is recommended for patients with pulmonary cryptococcosis, regardless of other risk factors. This study explored clinical and laboratory features to help predict which patients had pulmonary disease alone versus those who had pulmonary plus extrapulmonary disease. A retrospective chart review at 15 medical centers was performed from 1990 to 2000 of all HIV-negative patients who had pulmonary cryptococcosis. Demographic, clinical, radiographic, and laboratory features were evaluated to determine factors that differentiated those patients who had extrapulmonary disease. Among 166 patients who had pulmonary cryptococcosis, 122 had pulmonary infection only and 44 had pulmonary plus extrapulmonary (disseminated) disease. A negative serum cryptococcal antigen titer was more common in patients with pulmonary disease alone (p < 0.01). Multivariate analysis demonstrated that patients who had disseminated disease were more likely than those who only had pulmonary disease to have cirrhosis (p = 0.049), headache (p < 0.001), weight loss (p = 0.003), fever (p = 0.035), altered mental status (p < 0.001), and to be receiving high-dose corticosteroids (p = 0.008). In this large cohort of HIV-negative patients with pulmonary cryptococcosis, there were easily distinguished clinical and laboratory features among patients with pulmonary disease alone versus those with pulmonary plus extrapulmonary disease. These findings may be helpful in the evaluation of HIV-negative patients with pulmonary cryptococcosis with regard to the need for lumbar puncture or to search for disseminated disease.
Literature
1.
go back to reference Levitz SM (1991) The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 13(6):1163–1169PubMed Levitz SM (1991) The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 13(6):1163–1169PubMed
2.
go back to reference Chayakulkeeree M, Perfect JR (2006) Cryptococcosis. Infect Dis clin North Am 20(3):507–544 v–viPubMedCrossRef Chayakulkeeree M, Perfect JR (2006) Cryptococcosis. Infect Dis clin North Am 20(3):507–544 v–viPubMedCrossRef
3.
go back to reference Pappas PG, Perfect JR, Cloud GA et al (2001) Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 33(5):690–699PubMedCrossRef Pappas PG, Perfect JR, Cloud GA et al (2001) Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 33(5):690–699PubMedCrossRef
4.
go back to reference Dromer F, Mathoulin S, Dupont B, Brugiere O, Letenneur L (1996) Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. French Cryptococcosis Study Group. Clin Infect Dis 22 [Suppl 2]:S154–S160PubMed Dromer F, Mathoulin S, Dupont B, Brugiere O, Letenneur L (1996) Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. French Cryptococcosis Study Group. Clin Infect Dis 22 [Suppl 2]:S154–S160PubMed
5.
go back to reference Saag MS, Graybill RJ, Larsen RA et al (2000) Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 30(4):710–718PubMedCrossRef Saag MS, Graybill RJ, Larsen RA et al (2000) Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 30(4):710–718PubMedCrossRef
6.
go back to reference Saag MS, Powderly WG, Cloud GA et al (1992) Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med 326(2):83–89PubMed Saag MS, Powderly WG, Cloud GA et al (1992) Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med 326(2):83–89PubMed
7.
go back to reference Van der Horst CM, Saag MS, Cloud GA et al (1997) Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med 337(1):15–21PubMedCrossRef Van der Horst CM, Saag MS, Cloud GA et al (1997) Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med 337(1):15–21PubMedCrossRef
8.
go back to reference Dismukes WE (1993) Management of cryptococcosis. Clin Infect Dis 17 [Suppl 2]:S507–S512PubMed Dismukes WE (1993) Management of cryptococcosis. Clin Infect Dis 17 [Suppl 2]:S507–S512PubMed
9.
go back to reference Bennett JE, Dismukes WE, Duma RJ et al (1979) A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal [sic] meningitis. N Engl J Med 301(3):126–131PubMed Bennett JE, Dismukes WE, Duma RJ et al (1979) A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal [sic] meningitis. N Engl J Med 301(3):126–131PubMed
10.
go back to reference Dismukes WE, Cloud G, Gallis HA et al (1987) Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med 317(6):334–341PubMed Dismukes WE, Cloud G, Gallis HA et al (1987) Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med 317(6):334–341PubMed
11.
go back to reference Kerkering TM, Duma RJ, Shadomy S (1981) The evolution of pulmonary cryptococcosis: clinical implications from a study of 41 patients with and without compromising host factors. Ann Intern Med 94(5):611–616PubMed Kerkering TM, Duma RJ, Shadomy S (1981) The evolution of pulmonary cryptococcosis: clinical implications from a study of 41 patients with and without compromising host factors. Ann Intern Med 94(5):611–616PubMed
12.
go back to reference Aberg JA, Mundy LM, Powderly WG (1999) Pulmonary cryptococcosis in patients without HIV infection. Chest 115(3):734–740PubMedCrossRef Aberg JA, Mundy LM, Powderly WG (1999) Pulmonary cryptococcosis in patients without HIV infection. Chest 115(3):734–740PubMedCrossRef
13.
go back to reference Aberg JA (2003) Pulmonary cryptococcosis in normal hosts: treat or observe? Chest 124(6):2049–2051PubMedCrossRef Aberg JA (2003) Pulmonary cryptococcosis in normal hosts: treat or observe? Chest 124(6):2049–2051PubMedCrossRef
14.
go back to reference Woodring JH, Ciporkin G, Lee C, Worm B, Woolley S (1996) Pulmonary cryptococcosis. Semin Roentgenol 31(1):67–75PubMedCrossRef Woodring JH, Ciporkin G, Lee C, Worm B, Woolley S (1996) Pulmonary cryptococcosis. Semin Roentgenol 31(1):67–75PubMedCrossRef
15.
go back to reference Nadrous HF, Antonios VS, Terrell CL, Ryu JH (2003) Pulmonary cryptococcosis in nonimmunocompromised patients. Chest 124(6):2143–2147PubMedCrossRef Nadrous HF, Antonios VS, Terrell CL, Ryu JH (2003) Pulmonary cryptococcosis in nonimmunocompromised patients. Chest 124(6):2143–2147PubMedCrossRef
16.
go back to reference Kontoyiannis DP, Peitsch WK, Reddy BT et al (2001) Cryptococcosis in patients with cancer. Clin Infect Dis 32(11):E145–E150PubMedCrossRef Kontoyiannis DP, Peitsch WK, Reddy BT et al (2001) Cryptococcosis in patients with cancer. Clin Infect Dis 32(11):E145–E150PubMedCrossRef
17.
go back to reference Ascioglu S, Rex JH, de Pauw B et al (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34(1):7–14PubMedCrossRef Ascioglu S, Rex JH, de Pauw B et al (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34(1):7–14PubMedCrossRef
18.
go back to reference Larsen RA, Leal MA, Chan LS (1990) Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. Ann Intern Med 113(3):183–187PubMed Larsen RA, Leal MA, Chan LS (1990) Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. Ann Intern Med 113(3):183–187PubMed
19.
go back to reference Bicanic T, Meintjes G, Wood R et al (2007) Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Clin Infect Dis 45(1):76–80PubMedCrossRef Bicanic T, Meintjes G, Wood R et al (2007) Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Clin Infect Dis 45(1):76–80PubMedCrossRef
20.
go back to reference Brouwer AE, Rajanuwong A, Chierakul W et al (2004) Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet 363(9423):1764–1767PubMedCrossRef Brouwer AE, Rajanuwong A, Chierakul W et al (2004) Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet 363(9423):1764–1767PubMedCrossRef
21.
go back to reference Perfect JR (1989) Cryptococcosis. Infect Dis Clin North Am 3(1):77–102PubMed Perfect JR (1989) Cryptococcosis. Infect Dis Clin North Am 3(1):77–102PubMed
22.
go back to reference Singh N, Husain S, De Vera M, Gayowski T, Cacciarelli TV (2004) Cryptococcus neoformans infection in patients with cirrhosis, including liver transplant candidates. Medicine 83(3):188–192PubMedCrossRef Singh N, Husain S, De Vera M, Gayowski T, Cacciarelli TV (2004) Cryptococcus neoformans infection in patients with cirrhosis, including liver transplant candidates. Medicine 83(3):188–192PubMedCrossRef
23.
go back to reference Park WB, Choe YJ, Lee KD et al (2006) Spontaneous cryptococcal peritonitis in patients with liver cirrhosis. Am J Med 119(2):169–171PubMedCrossRef Park WB, Choe YJ, Lee KD et al (2006) Spontaneous cryptococcal peritonitis in patients with liver cirrhosis. Am J Med 119(2):169–171PubMedCrossRef
24.
go back to reference El-Serag HB, Anand B, Richardson P, Rabeneck L (2003) Association between hepatitis C infection and other infectious diseases: a case for targeted screening? Am J Gastroenterol 98(1):167–174PubMedCrossRef El-Serag HB, Anand B, Richardson P, Rabeneck L (2003) Association between hepatitis C infection and other infectious diseases: a case for targeted screening? Am J Gastroenterol 98(1):167–174PubMedCrossRef
25.
go back to reference Robinson PA, Bauer M, Leal MA et al (1999) Early mycological treatment failure in AIDS-associated cryptococcal meningitis. Clin Infect Dis 28(1):82–92PubMedCrossRef Robinson PA, Bauer M, Leal MA et al (1999) Early mycological treatment failure in AIDS-associated cryptococcal meningitis. Clin Infect Dis 28(1):82–92PubMedCrossRef
26.
go back to reference Singh N, Alexander BD, Lortholary O et al (2008) Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen. Clin Infect Dis 46(2):e12–e18PubMedCrossRef Singh N, Alexander BD, Lortholary O et al (2008) Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen. Clin Infect Dis 46(2):e12–e18PubMedCrossRef
27.
go back to reference Dromer F, Mathoulin-Pelissier S, Launay O, Lortholary O (2007) Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med 4(2):e21PubMedCrossRef Dromer F, Mathoulin-Pelissier S, Launay O, Lortholary O (2007) Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med 4(2):e21PubMedCrossRef
28.
go back to reference Vilchez RA, Irish W, Lacomis J, Costello P, Fung J, Kusne S (2001) The clinical epidemiology of pulmonary cryptococcosis in non-AIDS patients at a tertiary care medical center. Medicine 80(5):308–312PubMedCrossRef Vilchez RA, Irish W, Lacomis J, Costello P, Fung J, Kusne S (2001) The clinical epidemiology of pulmonary cryptococcosis in non-AIDS patients at a tertiary care medical center. Medicine 80(5):308–312PubMedCrossRef
29.
go back to reference Vilchez RA, Linden P, Lacomis J, Costello P, Fung J, Kusne S (2001) Acute respiratory failure associated with pulmonary cryptococcosis in non-aids patients. Chest 119(6):1865–1869PubMedCrossRef Vilchez RA, Linden P, Lacomis J, Costello P, Fung J, Kusne S (2001) Acute respiratory failure associated with pulmonary cryptococcosis in non-aids patients. Chest 119(6):1865–1869PubMedCrossRef
30.
go back to reference Chang WC, Tzao C, Hsu HH et al (2006) Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients. Chest 129(2):333–340PubMedCrossRef Chang WC, Tzao C, Hsu HH et al (2006) Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients. Chest 129(2):333–340PubMedCrossRef
Metadata
Title
Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease
Authors
J. W. Baddley
J. R. Perfect
R. A. Oster
R. A. Larsen
G. A. Pankey
H. Henderson
D. W. Haas
C. A. Kauffman
R. Patel
A. K. Zaas
P. G. Pappas
Publication date
01-10-2008
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2008
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-008-0529-z

Other articles of this Issue 10/2008

European Journal of Clinical Microbiology & Infectious Diseases 10/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine